Introduction
A better understanding of the spatiotemporal regulation of signal transduction is one of the most essential themes in the field of cell biology. The development of fluorescent proteins, which allow for the visualization of the dynamics of protein localization, activation/inactivation, and cellular events, was a breakthrough in promoting this area of interest. Green fluorescent protein (GFP) was isolated from jellyfish by Shimomura. Furthermore, the development of these GFP color variants has enabled researchers to visualize protein-protein interactions, enzyme activity, lipid synthesis, and ion dynamics in living cells using biosensors based on the principle of Förster (or fluorescence) resonance energy transfer (FRET). 5 FRET is a phenomenon of radiationless excitation energy transfer from a donor chromophore to an acceptor chromophore. Only when the acceptor and donor are close to each other can FRET signals be observed.
The concept of fluorescent protein-based biosensors used for live-cell imaging is thereby to convert a biological event, including signal transduction, membrane trafficking, or cellular environmental change, into an optical signal that can be detected by fluorescence microscopy. The first FRET-based biosensor using fluorescent proteins was engineered in 1997 by Miyawaki and Tsien to measure the intracellular calcium concentration (Fig. 1A) . 6, 7 Accumulating evidence indicates the importance of spatiotemporal regulation in determining the diversity and specificity of intracellular signaling. For example, we have reported that phosphoinositide 3-kinase (PI3K) is bound to the small GTPase Ras (Fig. 2 ) in endosomes, 8 and that Ras-PI3K signaling from the endosome is specifically involved in the regulation of clathrin-independent (but not clathrin-mediated) endocytosis. 9 Calcium signaling has also been identified as an upstream controller of such distinct regulation (Fig. 3) . 10 Because these achievements have depended to a large extent on live-cell imaging using fluorescent protein-based biosensors, we summarize herein the biosensors that are useful for visualizing signal transduction beneath the plasma membrane. 
Imaging of Ion Dynamics
After the discovery of Ras-PI3K signaling emanating from the endosome as a mediator of endocytosis and influenza virus entry, 8, 9 we focused on the mechanism by which Ras is activated upon influenza virus infection. Calcium signaling was thereby identified as an upstream factor for Ras activation through the observation of calcium dynamics during virus infection using the FRET-based calcium ion sensor Cameleon (Fig. 1A) . 6, 7 This biosensor is one of the oldest genetically encoded calcium indicators (GECIs), and it consists of the calcium-binding protein calmodulin (CaM), the calmodulin-binding domain of myosin light chain kinase (M13), and two fluorescent proteins. CaM bound to calcium ions changes its conformation and enwraps the M13 peptide, bringing the donor and acceptor chromophores close enough to each other to generate a FRET signal. Although the original version of Cameleon harbored a BFP and GFP chromophore pair, the improved version, Yellow Cameleon 3.60, in which ECFP and the circular permutated Venus (a brighter mutant of EYFP) are used, is widely employed today. Using this GECI, repeated, transient elevations in the intracellular calcium ion concentration after influenza virus infection were successfully observed by dual-emission fluorescence microscopy (Fig. 1B) . 10 Recently, Cameleon was further improved by Horikawa and Nagai with respect to its measurable range of calcium concentrations by engineering the Ca 2+ -sensing domain of Cameleon. This biosensor, Cameleon-Nano, achieved a higher Ca 2+ affinity, which resulted in approximately a 50-fold reduction in its Kd value (to 15 nM) compared with the classical Cameleon protein. 11 This biosensor can detect fluctuations in the basal calcium concentration in D. discoideum that have never been detected by previous GECIs. Alongside the evolution of Cameleon, an alternative FRET-based calcium sensor has also been developed whose calcium-sensing domain is troponin C, called TN-XXL. 12 In addition, single-fluorescent protein-based GECIs, including G-CaMP, 13 GECO, 14 Case12, 15 Pericam, 16 and Camgaroo, 17 have also been developed. These indicators are designed such that the fluorescence intensity is increased by increased intracellular Ca 2+ levels due to the insertion of a Ca
2+
-sensing region into these fluorescent proteins. The advantage of such indicators, which only require a single spectral observation unlike FRETbased Ca 2+ indicators, is to allow researchers to easily employ other spectral sources for multi-color imaging or optogenetics. For example, because channel rhodopsins are activated by blue light (488 nm), 18 typical FRET-based calcium sensors consisting of CFP and YFP, which require similar excitation spectra, cannot be used simultaneously. In contrast, single red fluorescent protein-based calcium sensors (e.g., R-GECO 14 ) can serve to monitor [Ca 2+ ]i in rhodopsin-expressing cells. Genetically encoded sensors for H + , [19] [20] [21] Cl -, 22 and Zn 2+ 23 have also been developed. Together with the further development of sensors for yet-untracked ions (Na + , K + , Mg 2+ , etc.), such efforts in ion visualization may lead to a comprehensive understanding of the ion dynamics in living cells.
Visualization of Small GTPase Activation
The Ras proteins are monomeric GTPases that play pivotal roles in the regulation of a variety of signal transduction cascades that are crucial for fundamental cellular functions (Fig. 2) . 24, 25 More than ten effectors have been identified, and this variety is responsible for the many facets of such functions. To understand the precise mechanism of Ras signaling, spatiotemporal analysis is needed. Matsuda and his colleagues developed FRET-based biosensors for the activation of the small GTPases Ras and Rap1, which were named Raichu (Ras and interacting protein chimeric unit) (Fig. 4A ). 26 The biosensors were designed to detect the binding of activated Ras or Rap1 to the Ras-binding 30 and Rab5. 31 Several groups have also reported on other biosensors for small GTPases, including RhoA, 32 and Cdc42, 33 whose components are similar to Raichu but are permutated compared with Raichu biosensors.
Single fluorescent protein-based biosensors are also available. The fluorescent protein tagged-RBD of Raf dictate the Ras activity by changing its intracellular localization (i.e., translocation from the cytosol to the plasma membrane by binding to activated Ras). 34 A similar biosensor has been developed to monitor the activity of the Rho family GTPase Cdc42 using a fluorescent protein fused to the GTPase-binding domain of WASP. 35 In our study, the Raichu biosensors were employed to monitor the signaling events downstream of the calcium flux induced by influenza viruses. We found that influenza viruses induce Ras activation at 10 min after infection, and that the activation is abolished by the chelation of intracellular calcium, thus confirming that calcium transmits signals from the viruses to Ras (Fig. 4B) . 10 Furthermore, we also revealed that the virusdependent calcium elevation triggered RhoA activation only at the periphery of the plasma membrane, as visualized by RaichuRhoA (Fig. 5) . 29 The region of RhoA activation was too restricted for the activation to be detected by conventional biochemical methods. 10 Imaging-based techniques might thereby maximize the researchers' ability to visualize such compartmentalized phenomena that have remained undiscovered by conventional approaches.
Phospholipid Localization
Phosphoinositides are a family of phospholipids that have an indispensable role in cellular processes, including membrane trafficking. For instance, during clathrin-dependent endocytosis, a well-studied class of endocytosis, the production of phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2] induces the assembly of the adaptor protein clathrin and subsequent coated pit formation.
In addition, the production of phosphatidylinositol 3-phosphate [PtdIns(3)P] in the endosome tethers early endosome-associated antigen 1 (EEA1) and facilitates homodimer formation, which together lead to endosomal maturation. 36, 37 The phosphoinositides thereby act as a platform for the assembly of functional proteins that are essential for endocytic processes, underscoring the particular importance of spatiotemporal regulation in their production.
A series of fusion proteins between a fluorescent protein and a domain that binds to specific phosphoinositide have been developed to visualize the spatiotemporal mobilization of phospholipids in living cells. 46, 47 With the use of CFP-tagged Akt-PH (Akt-PH-CFP) for the visualization of the PI3K products PtdIns(3,4,5)P3 and PtdIns(3,4)P2, we have shown that the PI3K that translocates from the plasma membrane to the endosome due to Ras is indeed activated based on the accumulation of Akt-PH-CFP induced by Ras activation.
Although such fluorescent protein-fused PH/PX/FYVE domains are widely used to visualize a dynamic change in phosphoinositides in living cells, they require careful attention to perform experiments and to interpret the obtained data because this method solely depends on the fluorescence intensity changes in a particular region of the cell. Generally, GFPtagged biosensors can generate false-positive signals in regions with a small ratio of plasma membrane surface area to cytosolic volume. 48 For instance, an increase in the fluorescence intensity evoked by a change in the membrane architecture, including membrane ruffling and membrane stacking, may mislead researchers to believe that biosensor accumulation has indeed occurred. In contrast, excess expression of fusion proteins in the cytosol may mask their membrane translocation. Moreover, because such biosensors report the abundance of phospholipids in a translocation-dependent manner, it is wholly unreasonable to generate biosensors that reside in a specific organelle, which would limit their ability to detect a minute change in a small compartment.
To overcome these issues, dual-emission phosphoinositide biosensors have been developed based on the principle of FRET that include an indicator of the various phosphoinositides: for PtdIns(3,4,5)P3, Pippi-PIP3/Fllip; 49 for PtdIns(4,5)P2 and PtdIns(3,4,5)P3, CAY; 50 for PtdIns(3,4)P2 and PtdIns(3,4,5)P3, InPAkt; 51 and for InsP3, fretino. 52 Furthermore, by adding organelle-targeting signals to FRET-based biosensors, localized changes in a specific region of an organelle can be visualized with increased sensitivity.
Clinical Applications of FRET Biosensors
As described above, FRET imaging can provide spatiotemporal information about intracellular signaling in a highly sensitive and quantitative manner in living cells. Recently, we have developed a FRET biosensor with the aim of a clinical application by virtue of such properties using chronic myeloid leukemia (CML) as a model disease.
CML is a hematopoietic malignancy that is characterized by the presence of the Philadelphia chromosome (Ph1). Ph1 results from a reciprocal translocation between chromosomes 9 and 22, leading to the formation of the novel fusion gene bcr-abl and subsequent expression of the constitutively active tyrosine kinase BCR-ABL. BCR-ABL phosphorylates a variety of substrates, including CrkL, thereby promoting leukemogenesis. Over a decade ago, the tyrosine kinase inhibitor of BCL-ABL imatinib mesylate was clinically approved, and secondgeneration drugs were later launched following the clinical success of the original drug. However, no clinical tests are available to judge which drug may achieve maximal effect in a given individual patient prior to treatment. Therefore, we aimed to develop a novel assay to predict drug efficacy before administration that would guarantee that CML patients receive effective and secure therapy, i.e., "tailor-made therapy".
To this aim, we developed an FRET-based biosensor that monitors BCR-ABL activity in living CML cells. The biosensor consists of CrkL and a pair of CFP and YFP variants and is called Pickles after the phosphorylation indicator of CrkL en substrate. With this biosensor, we succeeded in monitoring drug responses at the single-cell level and detecting a minor population of drug-resistant cells among a heterogeneous population of CML patient cells. 53 Furthermore, a series of clinical trials with Pickles demonstrated that our initial aimpredicting and proposing the most effective drug for each individual CML patient-would come to fruition.
Improvement of FRET Biosensors
To develop high-performance FRET-based biosensors, various strategies have been introduced and refined. Because FRET efficiency theoretically depends on spectral overlap (the so-called J value), the distance (r), and the relative orientation (orientation coefficient, κ 2 ) between the acceptor and donor chromophores, most strategies solely focus on the alignment of these factors.
The J value is an integral of the spectral overlap of the donor emission and acceptor excitation. Given that FRET efficiency increases proportionally with this value, the selection of a fluorescent protein pair is critical for creating a high-performance FRET-based biosensor. For example, Lin's group engineered the optimized fluorescent proteins Clover (a derivative of Aequorea victoria GFP) and mRuby2 [a derivative of DsRed (RFP)] as a donor and acceptor pair, respectively, for FRET biosensors with high yield. With respect to several FRET-based biosensors, including that for RhoA (Raichu-RhoA), 29 that for PKA (AKAR2), 54 that for membrane potential (VSFP), 55 and that for CaMKIIα (Camuiα), 56 their FRET dynamic ranges and emission ratio changes have been improved up to 1.5-fold by substitution for the donor and acceptor fluorescent proteins. 57 One of the disadvantages of intramolecular FRET biosensors is that it takes substantial effort to optimize them for maximum sensitivity. To overcome this issue, Matsuda and his colleagues established a system for an optimized backbone consisting of a long and flexible peptide linker (EV linker) and an optimized pair of fluorescent proteins. 58 The EV linker, a peptide that is 116 amino acids in length and consists of SAGG repeats, reduces the basal FRET signal due in part to an increase in r in the OFF state and therefore increases the gain of FRET-based sensors between the OFF and ON states. It may be noteworthy that this system can be widely adapted for a variety of FRETbased biosensors, including those for kinases and those for GTPases. In contrast, in the case of Cameleon-Nano, the insertion of a peptide linker into FRET-based biosensors lowered the Kd value, shifting the measureable range of calcium concentration lower.
Another major method that is utilized for biosensor improvement is circular permutation 17 in which new N-and C-termini are created within a fluorescent protein. The resulting two fragments are shuffled, and the original C-and N-termini are reconnected by a short spacer peptide. Circular permutation is expected to alter the relative orientation of the chromophore to its fusion partner through a rearrangement of the amino-acid sequence without any substitution of the amino-acid composition. It has thus been introduced in anticipation of an improved κ 2 to refine many biosensors, including Yellow Cameleon, 6, 16 ATeam, 59 and Pickles. 53 However, given that all improved versions of biosensors adopt the same circular permutation (cp173), the consequent improvements obtained might be accounted for by other mechanisms than the alteration in their relative orientations.
Methods for Handling Fluorescent Proteinbased Biosensors
The most widely used method for the observation of fluorescent protein-based biosensors is fluorescence microscopy although any equipment that can detect fluorescence signal, which includes fluorescence plate readers and fluorescence spectrometers may be used. Using microscopy, dynamic cellular events, including morphological changes, migration, and cytokinesis, can be analyzed in living cells or organisms, concomitant with lipid metabolism, protein activation, and ion dynamics, which are reported by biosensors. General requirements for such experiments include a conventional epifluorescence microscope, a cooled charge-coupled device (CCD) or a complementary metal-oxide-semiconductor (CMOS) sensor for image acquisition, and filters suited for the excitation and emission spectra of the fluorescent proteins that are harbored in biosensors (see also Table 1 ). A mechanical shutter(s) under the control of imaging software is essential in time-lapse experiments to avoid excess exposure of cells to light during the periods of acquisition. Alternatively, this can also be achieved using a light-emitting-diodes (LED)-based light source and its on-off switching by imaging software, however. For multicolor imaging including FRET imaging, filter wheels, in which filters are set are also required. Because most FRET-based biosensors introduced here are based on the intramolecular FRET system, in which FRET indices are estimated by simply calculating the ratio of acceptor emission to donor emission, it is possible to obtain FRET indices from simultaneous acquisition of emission images using a spectral separator. Such equipment enables imaging with high temporal resolution. Three-dimensional (3D) imaging of biosensors can be performed using confocal laser scanning microscopy (CLSM), spinning disk confocal microscopy (SDCM), or multiphoton excitation fluorescence microscopy (MPM). After image acquisition, image-processing software may help to monitor the change in fluorescence intensity or calculate FRET efficiency for each pixel.
Conclusion and Perspective
In this review, we have summarized fluorescent protein-based biosensors used for monitoring ion dynamics, small GTPase activity, lipid metabolism, and tyrosine kinase activity in living cells. Other than these targets, FRET-based biosensors for serine/threonine kinases, cyclic nucleotides, glucose, etc., have also been developed. [60] [61] [62] The number of cellular events that can be visualized using such fluorescent protein-based biosensors will continue to grow. Furthermore, we believe that the field of application for fluorescent biosensors can be widened from basic science research to clinical applications.
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